# Ibuprofen 400MG/600MG/800MG Tablets

Canonical: https://abierto.us/opportunities/spe2d224d0003

- Solicitation number: SPE2D2-24-D-0003
- Notice type: Award notice
- Status: Awarded to Exelan Pharmaceuticals Inc. for $6,984,109.81
- Department: Department of Defense
- Agency: Defense Logistics Agency
- Contracting office: DLA Troop Support (SPE2D2)
- NAICS: 325412 Pharmaceutical Preparation Manufacturing
- Product or service code: 6505 Drugs and Biologicals
- First posted: February 12, 2024
- Last posted: February 5, 2025
- SAM.gov: https://sam.gov/workspace/contract/opp/d8ea56c3ff734378bcd0e2e8a5f21a90/view

## Description

Modification SPE2D224D0003 P00002 to exercise Option Year 1 effective February 12, 2025 through February 11, 2026. Modification SPE2D224D0003 P00001 to incorporate FAR 52.204-30 Federal Acquisition Supply Chain Security Act Orders language into solicitation for subject contract.

## Award on USAspending

- Recipient: Exelan Pharmaceuticals Inc. (UEI FYZXNHSQTMG8)
- Contract: SPE2D224D0003
- Obligated: $0.00
- Competition: Full and Open Competition, 3 offers received
- Link: award number SPE2D224D0003 equals the contract number; same awarding office SPE2D2 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_IDV_SPE2D224D0003_9700/


## Publications

- February 12, 2024: Award notice. Notice db6d7688e921453c98d43a1127ff253b. https://sam.gov/workspace/contract/opp/db6d7688e921453c98d43a1127ff253b/view
- February 5, 2025: Award notice. Notice d8ea56c3ff734378bcd0e2e8a5f21a90. https://sam.gov/workspace/contract/opp/d8ea56c3ff734378bcd0e2e8a5f21a90/view

## Points of contact

- Kyle Lewicki, kyle.lewicki@dla.mil, 2157373696
- Jason Wray, jason.wray@dla.mil, 2157370614

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/spe2d224d0003.